Which combination should be preferred in the management of children with chronic hepatitis B infection?
Dikici
Bunyamin
B
Ece
Aydin
A
Bosnak
Mehmet
M
D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D003657:Decision Making; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D019259:Lamivudine / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome
D000998:Antiviral Agents; D016898:Interferon-alpha; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine